Literature DB >> 11220745

Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E.

P De Jonghe1, I Mersivanova, E Nelis, J Del Favero, J J Martin, C Van Broeckhoven, O Evgrafov, V Timmerman.   

Abstract

A missense mutation in the neurofilament light chain gene (NEFL, NF-L) at chromosome 8p21 was recently reported in a single Charcot-Marie-Tooth type 2 family (CMT2). This new CMT2 variant is designated CMT2E. The NEFL gene mutation showed co-segregation with the disease phenotype and is thus most likely the disease-causing mutation. However, the possibility that it is a closely linked rare polymorphism can not be ruled out with certainty. We observed a novel NEFL missense mutation in a second CMT family, providing supporting evidence that CMT2E is caused by NEFL gene mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11220745     DOI: 10.1002/1531-8249(20010201)49:2<245::aid-ana45>3.0.co;2-a

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  40 in total

1.  Glu528del in NEFL is a polymorphic variant rather than a disease-causing mutation for Charcot-Marie-Tooth disease in Japan.

Authors:  Masahiko Yamamoto; Tsuyoshi Yoshihara; Naoki Hattori; Gen Sobue
Journal:  Neurogenetics       Date:  2003-10-29       Impact factor: 2.660

2.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

3.  Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E.

Authors:  J M Dale; E Villalon; S G Shannon; D M Barry; R M Markey; V B Garcia; M L Garcia
Journal:  Genes Brain Behav       Date:  2012-02-23       Impact factor: 3.449

4.  Comparison of CMT1A and CMT2: similarities and differences.

Authors:  Henriette M E Bienfait; Camiel Verhamme; Ivo N van Schaik; Johannes H T M Koelman; Bram W Ongerboer de Visser; Rob J de Haan; Frank Baas; Baziel G M van Engelen; Marianne de Visser
Journal:  J Neurol       Date:  2006-08-28       Impact factor: 4.849

5.  Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.

Authors:  Hailian Shen; Devin M Barry; Jeffrey M Dale; Virginia B Garcia; Nigel A Calcutt; Michael L Garcia
Journal:  Hum Mol Genet       Date:  2011-04-14       Impact factor: 6.150

6.  Differential expression of cytoskeletal genes in the cochlear nucleus.

Authors:  David R Friedland; Paul Popper; Rebecca Eernisse; Benjamin Ringger; Joseph A Cioffi
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-04

Review 7.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

8.  Charcot-marie-tooth disease: seventeen causative genes.

Authors:  Jung-Hwa Lee; Byung-Ok Choi
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

9.  Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease.

Authors:  Marian A J Weterman; Fred van Ruissen; Marit de Wissel; Lou Bordewijk; Johnny P A Samijn; W Ludo van der Pol; Farid Meggouh; Frank Baas
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

10.  Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.

Authors:  Natalia Ninkina; Owen Peters; Steven Millership; Hatem Salem; Herman van der Putten; Vladimir L Buchman
Journal:  Hum Mol Genet       Date:  2009-02-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.